N Takano1,2, M Suzuki3,2, R Irie2, M Yamamoto4, K Teranishi4, K Yatomi4, N Hamasaki2, K K Kumamaru3,2, M Hori3,2, H Oishi4,5, S Aoki3,2. 1. From the Department of Radiology (N.T., M.S., K.K.K., M.H., S.A.), Graduate School of Medicine, Juntendo University, Tokyo, Japan ntakano@juntendo.ac.jp. 2. Department of Radiology (N.T., M.S., R.I., N.H., K.K.K., M.H., S.A.), Juntendo University Hospital, Tokyo, Japan. 3. From the Department of Radiology (N.T., M.S., K.K.K., M.H., S.A.), Graduate School of Medicine, Juntendo University, Tokyo, Japan. 4. Departments of Neurosurgery (M.Y., K.T., K.Y., H.O.). 5. Neuroendovascular Therapy (H.O.), Juntendo University School of Medicine, Tokyo, Japan.
Abstract
BACKGROUND AND PURPOSE: The Low-Profile Visualized Intraluminal Support Device comprises a small-cell nitinol structure and a single-wire braided stent that provides greater metal coverage than previously reported intracranial stents, as well as assumed strong susceptibility artifacts. This study aimed to assess the benefits of non-contrast-enhanced MRA by using a Silent Scan (Silent MRA) for intracranial anterior circulation aneurysms treated with Low-Profile Visualized Intraluminal Support Device stents. MATERIALS AND METHODS: Thirty-one aneurysms treated with Low-Profile Visualized Intraluminal Support Device stents were assessed by using Silent MRA, 3D TOF-MRA, and x-ray DSA. The quality of MRA visualization of the reconstructed artery was graded on a 4-point scale from 1 (not visible) to 4 (excellent). Aneurysm occlusion status was evaluated by using a 2-grade scale (total occlusion/remnant [neck or aneurysm]). Weighted κ statistics were used to evaluate interobserver and intermodality agreement. RESULTS: The mean scores ± SDs for Silent MRA and 3D TOF-MRA were 3.16 ± 0.79 and 1.48 ± 0.67 (P < .05), respectively, with substantial interobserver agreement (κ = 0.66). The aneurysm occlusion rates of the 2-grade scale (total occlusion/remnant [neck or aneurysm]) were 69%/31% for DSA, 65%/35% for Silent MRA, and 92%/8% for 3D TOF-MRA, respectively. The intermodality agreements were 0.88 and 0.30 for DSA/Silent MRA and DSA/3D TOF-MRA, respectively. CONCLUSIONS: Silent MRA seems to be useful for visualizing intracranial anterior circulation aneurysms treated with Low-Profile Visualized Intraluminal Support Device stents.
BACKGROUND AND PURPOSE: The Low-Profile Visualized Intraluminal Support Device comprises a small-cell nitinol structure and a single-wire braided stent that provides greater metal coverage than previously reported intracranial stents, as well as assumed strong susceptibility artifacts. This study aimed to assess the benefits of non-contrast-enhanced MRA by using a Silent Scan (Silent MRA) for intracranial anterior circulation aneurysms treated with Low-Profile Visualized Intraluminal Support Device stents. MATERIALS AND METHODS: Thirty-one aneurysms treated with Low-Profile Visualized Intraluminal Support Device stents were assessed by using Silent MRA, 3D TOF-MRA, and x-ray DSA. The quality of MRA visualization of the reconstructed artery was graded on a 4-point scale from 1 (not visible) to 4 (excellent). Aneurysm occlusion status was evaluated by using a 2-grade scale (total occlusion/remnant [neck or aneurysm]). Weighted κ statistics were used to evaluate interobserver and intermodality agreement. RESULTS: The mean scores ± SDs for Silent MRA and 3D TOF-MRA were 3.16 ± 0.79 and 1.48 ± 0.67 (P < .05), respectively, with substantial interobserver agreement (κ = 0.66). The aneurysm occlusion rates of the 2-grade scale (total occlusion/remnant [neck or aneurysm]) were 69%/31% for DSA, 65%/35% for Silent MRA, and 92%/8% for 3D TOF-MRA, respectively. The intermodality agreements were 0.88 and 0.30 for DSA/Silent MRA and DSA/3D TOF-MRA, respectively. CONCLUSIONS: Silent MRA seems to be useful for visualizing intracranial anterior circulation aneurysms treated with Low-Profile Visualized Intraluminal Support Device stents.
Authors: J Mocco; Kenneth V Snyder; Felipe C Albuquerque; Bernard R Bendok; Boulos Alan S; Jeffrey S Carpenter; David J Fiorella; Brian L Hoh; Jay U Howington; Brian T Jankowitz; Kenneth M Liebman; Ansaar T Rai; Rafael Rodriguez-Mercado; Adnan H Siddiqui; Erol Veznedaroglu; L Nelson Hopkins; Elad I Levy Journal: J Neurosurg Date: 2009-01 Impact factor: 5.115
Authors: Alejandro M Spiotta; Amrendra Miranpuri; M Imran Chaudry; Raymond D Turner; Aquilla S Turk Journal: J Neurointerv Surg Date: 2012-11-20 Impact factor: 5.836
Authors: Andrew J Molyneux; Richard S C Kerr; Ly-Mee Yu; Mike Clarke; Mary Sneade; Julia A Yarnold; Peter Sandercock Journal: Lancet Date: 2005 Sep 3-9 Impact factor: 79.321
Authors: H Oishi; T Fujii; M Suzuki; N Takano; K Teranishi; K Yatomi; T Kitamura; M Yamamoto; S Aoki; H Arai Journal: AJNR Am J Neuroradiol Date: 2019-05-02 Impact factor: 3.825
Authors: P Shahrouki; R Gupta; P Belani; A Chien; A H Doshi; R De Leacy; J T Fifi; J Mocco; K Nael Journal: AJNR Am J Neuroradiol Date: 2022-06 Impact factor: 4.966
Authors: You Na Kim; Jin Wook Choi; Yong Cheol Lim; Jihye Song; Ji Hyun Park; Woo Sang Jung Journal: Korean J Radiol Date: 2022-01-04 Impact factor: 3.500